To overcome the short duration of therapeutic protein expression associated with mRNA, Sail Biomedicine has developed novel endless RNA constructs. Michael Lam, Ph.D., discusses its delivery mechanisms and an outlook for future applications.
- Biomaterials In Ophthalmology Are Reshaping Ocular Drug Delivery
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- Crossing The Brain's Barrier: Recent Advances And What Lies Ahead
- Navigating Combination Products: Device Complexity And Software Integration
- Improving Execution Of Biological Evaluation Of Drug Delivery Devices
- DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
- From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair
- Risk Is the Spine: What The First 100 QMSR Inspections Reveal
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Responding To Trends In Prefilled Delivery: Component Assessment And Selection
Existing plunger technology for PFS was developed for manual injection and does not meet the evolving requirements for drug delivery especially for consistency of injection rate.
-
Lyophilization Contract Manufacturing Services: What To Know
Explore the best ways to optimize your lyophilization cycle and the benefits of partnering with an experienced pharmaceutical contract manufacturing services provider.
-
4031 Ready Methods Reduce E&L Timelines
An established approach for executing extractables and leachables evaluations for individual drug products comprises understanding risks, developing and validating targeted leachables studies, and supporting drug products through stability testing.
-
Making A Case For A Fixed Dose Combination Drug Strategy
As patient-centricity spurs innovation in drug delivery systems, examine the potential of FDCs to provide convenient dosing and how increased patient compliance is alleviating the cost of health care.
-
Elastomer Plungers With Barrier Film For COVID-19 Vaccines
Minimize the risks of accelerated drug development processes and the potential use of new vaccine platform technologies with the use of an elastomer plunger laminated with FluroTec™ barrier film.
-
Leveraging Integration At Each Phase Of A Drug Delivery System Project
By forging deeper partnerships with customers, the full depth and breadth of our knowledge, experience and competencies can bring benefits at multiple levels. See how an integrated offering helps at each phase of a drug delivery system project.
-
Long-Term Container Closure Integrity Testing Of Vial-Stopper-Seal Combinations
The study was designed to investigate CCI over a period of 24 months at ambient, ultra-low and cryogenic temperatures for serum-stopper samples and at ambient temperature for lyo-stopper samples.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
Stainless Steel Needles: Quantifying Cobalt Risk For EU Regulation
Learn how a partner who is committed to ensuring the safety of medical devices by mitigating the risk of chemical interaction with drugs is crucial for navigating the regulatory pathway to approval.
-
Liposome Vs. Lipid Nanoparticle: What's The Difference?
Here, we discuss the differences between nanoparticles and liposomes along with their applications in medicine.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing
In this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk.

